(Q46855820)

25 December 2017

title

Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo (English)

1 reference

25 December 2017

author name string

Katsumi Shigemura

1

1 reference

25 December 2017

Toshiro Shirakawa

2

1 reference

25 December 2017

Yoshitaka Wada

3

1 reference

25 December 2017

Sadao Kamidono

4

1 reference

25 December 2017

Masato Fujisawa

5

1 reference

25 December 2017

Akinobu Gotoh

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

25 December 2017

published in

Urology

1 reference

25 December 2017

volume

66

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

1239-1244

1 reference

25 December 2017

Cancer research. Anti-inflammatories inhibit cancer growth--but how?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Host cyclooxygenase-2 modulates carcinoma growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Target to apoptosis: a hopeful weapon for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Androgen-repressed phenotype in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Assessment of the Alamar Blue assay for cellular growth and viability in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

TSH receptor status of thyroid neoplasms--TaqMan RT-PCR analysis of archival material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Demonstration of rat CAR bacillus using a labelled streptavidin biotin (LSAB) method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Expression of cyclooxygenase-2 protein in gastric adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.06.076

10.1016/J.UROLOGY.2005.06.076

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017